Home/Pipeline/Inherited Cancer Panel (NGS)

Inherited Cancer Panel (NGS)

Genetic cancer risk

Pre-commercialActive

Key Facts

Indication
Genetic cancer risk
Phase
Pre-commercial
Status
Active
Company

About YouSeq

YouSeq is a private, commercial-stage diagnostics company headquartered in Cambridge, UK, leveraging qPCR and Next-Generation Sequencing (NGS) technologies to develop multiplex test panels primarily for infectious diseases. The company emphasizes a large off-the-shelf product menu and custom panel development services, backed by ISO 13485 accreditation and a team with deep molecular diagnostics expertise. Its business model is centered on selling reagents and kits to diagnostic labs and researchers, with a growing global distribution network including US warehousing.

View full company profile